Carboxypeptidase E: elevated expression correlated with tumor growth and metastasis in pheochromocytomas and other cancers.
about
Carboxypeptidase E: a negative regulator of the canonical Wnt signaling pathwayTarget therapy in metastatic pheochromocytoma: current perspectives and controversiesAnalysis of gene expression data from non-small cell lung carcinoma cell lines reveals distinct sub-classes from those identified at the phenotype levelMeta-analysis of differentially expressed genes in osteosarcoma based on gene expression data.Integration of Breast Cancer Secretomes with Clinical Data Elucidates Potential Serum Markers for Disease Detection, Diagnosis, and Prognosis.Current approaches and recent developments in the management of head and neck paragangliomas.Carboxypeptidase E is a novel modulator of RANKL-induced osteoclast differentiation.Upregulation of CPE promotes cell proliferation and tumorigenicity in colorectal cancer.New roles of carboxypeptidase E in endocrine and neural function and cancer.18F-FLT PET/CT in the Evaluation of Pheochromocytomas and Paragangliomas: A Pilot Study.BCAT1 expression associates with ovarian cancer progression: possible implications in altered disease metabolism.Current and future therapeutic approaches for metastatic pheochromocytoma and paraganglioma: focus on SDHB tumors.Silencing of carboxypeptidase E inhibits cell proliferation, tumorigenicity, and metastasis of osteosarcoma cellsCarboxypeptidase E promotes cancer cell survival, but inhibits migration and invasionN-terminal truncated carboxypeptidase E expression is associated with poor prognosis of lung adenocarcinoma.The potential of carboxypeptidase M as a therapeutic target in cancer.Downregulation of CPE regulates cell proliferation and chemosensitivity in pancreatic cancer.SiRNA-targeted carboxypeptidase D inhibits hepatocellular carcinoma growth.The "go or grow" potential of gliomas is linked to the neuropeptide processing enzyme carboxypeptidase E and mediated by metabolic stress.Microarray analysis in a cell death resistant glioma cell line to identify signaling pathways and novel genes controlling resistance and malignancy.Carboxypeptidase E is a prediction marker for tumor recurrence in early-stage hepatocellular carcinoma.CPE overexpression is correlated with pelvic lymph node metastasis and poor prognosis in patients with early-stage cervical cancer.[Screening of Highly Expressed CPEΔN Lung Cancer H1299 Cells].Overexpression of CPE-ΔN predicts poor prognosis in colorectal cancer patients.
P2860
Q24294190-8A276EC2-D7F6-474F-BB93-F037FA90339DQ28087343-A740D8DB-318F-46D7-A48D-7170B5EB4FE3Q28485331-40047EED-3487-4C6B-8424-CBC2771E2D4EQ30836485-5D7CD7F1-FC29-43F7-A02C-67E0B6ED5491Q31111254-DC28D759-913C-491D-928E-45BCEE5D9C2AQ34204524-29B270DA-38FB-49F3-B752-F03098F8298AQ34263329-9642C457-7406-4BDF-BF3D-5C7CB9705D0BQ34978670-119BFD65-8EF1-4176-B115-DCD1D6050E9AQ36003395-E37713E4-AA81-4C32-857A-2700607A4507Q36342833-A636B487-5C9B-4B62-9BB4-AEA4B6302710Q36544617-D1A8F5A1-FDB4-42BF-BE97-9530A2645E8BQ36625228-7DCE899C-D678-45D1-8212-CED3A8D43637Q36907950-ED4AF82D-3585-48CB-9FC1-DA289709083EQ37302972-741B0FE8-4098-44FE-9E52-D3C6585A9130Q37582003-40D324C5-012A-4DB3-82A8-6C857D905A6FQ38072098-FE178EE3-CCC8-407B-9497-D23E07AB4B5AQ38942393-E1F0C9BD-F140-4D04-87EC-FE81DDD5757CQ39165661-D79A9173-000D-4892-BBEB-9E80E346F762Q39411316-B7A312FE-B877-4D49-BE46-D80F382630B5Q39614127-C0B556FD-2D91-47C5-8D97-C10F77D40104Q40068989-1D4BFCA3-5935-4C1D-AE23-E125439B4364Q40179896-3B620C36-232D-4998-A4B5-31FBDE810876Q41143257-251E3CE5-F545-48B5-BD7B-14771DF8220CQ44594513-B996BB86-9762-4DD9-A218-423DDE9AA341
P2860
Carboxypeptidase E: elevated expression correlated with tumor growth and metastasis in pheochromocytomas and other cancers.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Carboxypeptidase E: elevated e ...... romocytomas and other cancers.
@ast
Carboxypeptidase E: elevated e ...... romocytomas and other cancers.
@en
Carboxypeptidase E: elevated e ...... romocytomas and other cancers.
@nl
type
label
Carboxypeptidase E: elevated e ...... romocytomas and other cancers.
@ast
Carboxypeptidase E: elevated e ...... romocytomas and other cancers.
@en
Carboxypeptidase E: elevated e ...... romocytomas and other cancers.
@nl
prefLabel
Carboxypeptidase E: elevated e ...... romocytomas and other cancers.
@ast
Carboxypeptidase E: elevated e ...... romocytomas and other cancers.
@en
Carboxypeptidase E: elevated e ...... romocytomas and other cancers.
@nl
P2860
P1476
Carboxypeptidase E: elevated e ...... romocytomas and other cancers.
@en
P2093
Saravana R K Murthy
Y Peng Loh
P2860
P2888
P304
P356
10.1007/S10571-010-9592-Y
P50
P577
2010-11-01T00:00:00Z
P5875
P6179
1028208979